This website is intended for healthcare professionals only


Forthcoming guidance
 
Published guidance
 
Select guidance type:
Select Clinical speciality:

Date: from to

Search



Title Type Clinical speciality   Expected date   Last updated date
bevacizumab (Avastin) SMC advice Malignant Disease Sep 2016 -
dasatinib (Sprycel) SMC advice Malignant Disease Sep 2016 -
dasatinib (Sprycel) Second Line Treatment SMC advice Malignant Disease Sep 2016 -
canakinumab (Ilaris) SMC advice Malignant Disease Nov 2016 Nov 2016
Cerebral palsy in under 25s: assessment and management NICE Clinical Guideline Central Nervous System Jan 2017 Jan 2017
Combined hormonal contraception—update (Faculty of Sexual & Reproductive Healthcare) Independent professional body guideline Obstetrics, Gynaecology & Urology Jan 2017 Nov 2016
Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK (National Osteoporosis Guideline Group) Independent professional body guideline Musculoskeletal & Joints Jan 2017 Jan 2017
Infliximab for extrapulmonary sarcoidosis NICE Evidence summary: unlicensed/off-label medicines Respiratory Jan 2017 Nov 2016
ferric maltol (Feraccru®) All Wales Medicines Strategy Group appraisal Nutrition Jan 2017 Jan 2017
Falls: prevention NICE Quality Standard General Jan 2017 -
Leukaemia (chronic lymphocytic)—ibrutinib (Imbruvica) NICE Technology Appraisal Malignant Disease Jan 2017 -
Asthma (eosinophilic, severe)—mepolizumab (Nucala) NICE Technology Appraisal Respiratory Jan 2017 Dec 2016
Lymphoma (follicular, rituximab-refractory)—obinutuzumab (Gazyvaro) (with bendamustine) NICE Technology Appraisal Malignant Disease Jan 2017 Oct 2016
Multiple sclerosis (relapsing-remitting)—daclizumab (Zinbryta) NICE Technology Appraisal Central Nervous System Jan 2017 Oct 2016
Hepatitis C (chronic)—sofosbuvir and velpatasvir (Epclusa) NICE Technology Appraisal Infection Jan 2017 Oct 2016
Cutaneous melanoma (update) SIGN guidance Malignant Disease Jan 2017 -
Antimicrobial stewardship—changing risk-related behaviours in the general population NICE Public Health Guidance Infection Jan 2017 Nov 2016
Rhinitis management guidelines—update (British Society for Allergy and Clinical Immunology) Independent professional body guideline Eye, Ear, Nose & Throat Feb 2017 Oct 2016
Management of gout (British Society for Rheumatology) Independent professional body guideline Musculoskeletal & Joints Feb 2017 Nov 2016
Hidradenitis suppurativa—update (British Association of Dermatologists) Independent professional body guideline Skin Feb 2017 Jan 2017


COPD diagnosis, management and prevention
Global Initiative for Chronic Obstructive Lung Disease

Choosing an appropriate inhaler device for the treatment of adults with asthma or COPD
Development Group: Usmani, Capstick, Chowhan, & Scullion.
This management algorithm was developed by a multidisciplinary expert panel: Usmani et al with the support of a grant from Chiesi Ltd.

Summary of the management of asthma in children (from the British guideline on the management of asthma)
The British Thoracic Society & Scottish Intercollegiate Guidelines Network

Summary of the management of asthma in adults (from the British guideline on the management of asthma)
The British Thoracic Society & Scottish Intercollegiate Guidelines Network

Rosacea—primary care treatment pathway
Primary Care Dermatology Society

Choosing an appropriate inhaler device for the treatment of adults with asthma or COPD
Development Group: Usmani, Capstick, Chowhan, & Scullion.
This management algorithm was developed by a multidisciplinary expert panel: Usmani et al with the support of a grant from Chiesi Ltd.

COPD diagnosis, management and prevention
Global Initiative for Chronic Obstructive Lung Disease



Visit our NEW site!

Guidelines for Nurses provides current, credible summaries and feature articles developed especially for nurses.